Both in Pharmaceuticals
Lexaria Bioscience vs Actuate Therapeutics
Over the past year LEXX returned −75.6% and ACTU returned −94.2%; their daily moves had a correlation of 0.02.
LEXX −75.6% ACTU −94.2%Growth of $1, one year, split-adjusted
| Metric | LEXX | ACTU |
|---|---|---|
| Price | $4.07 | $0.3699 |
| Market cap | $8.6M | $8.9M |
| Today | +0.99% | +5.69% |
| 1 month | +25.6% | −54.4% |
| 6 months | −59.8% | −87.6% |
| Year to date | −56.0% | −94.0% |
| 1 year | −73.9% | −94.5% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 44.2× | — |
| Net cash | $3.6M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 195.3% | 161.7% |
| Short % of float | 16.0% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).